Jorge E Cortes Selected Research

Pneumonia (Pneumonitis)

1/2019	Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial.
1/2019	Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome.
9/2015	Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors.
10/2013	Pneumonia during remission induction chemotherapy in patients with acute leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jorge E Cortes Research Topics

Disease

128	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2024 - 07/2002
88	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 06/2002
53	Leukemia 12/2023 - 02/2002
46	Philadelphia Chromosome 12/2023 - 07/2002
38	Neoplasms (Cancer) 11/2023 - 07/2002
29	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 06/2002
25	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 07/2002
19	Blast Crisis (Blast Phase) 12/2021 - 03/2006
16	Hematologic Neoplasms (Hematological Malignancy) 09/2020 - 07/2002
13	Thrombocytopenia (Thrombopenia) 05/2024 - 09/2002
13	Exanthema (Rash) 06/2022 - 03/2003
12	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 05/2006
10	Neutropenia 01/2023 - 05/2006
10	Diarrhea 12/2018 - 03/2003
9	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021 - 06/2002
9	Disease Progression 10/2020 - 01/2007
8	Fatigue 01/2023 - 04/2004
7	Anemia 04/2024 - 06/2002
6	Hypertension (High Blood Pressure) 01/2023 - 01/2011
6	Nausea 01/2019 - 09/2003
6	Pleural Effusion (Pleural Effusions) 01/2019 - 06/2005
6	Chromosome Aberrations (Chromosome Abnormalities) 01/2018 - 04/2004
6	Residual Neoplasm 01/2018 - 12/2014
4	Febrile Neutropenia 01/2023 - 01/2018
4	Lymphoma (Lymphomas) 11/2022 - 01/2011
4	Pancreatitis 12/2019 - 11/2012
4	Pneumonia (Pneumonitis) 01/2019 - 10/2013
4	Fever (Fevers) 01/2019 - 01/2008
4	Systemic Mastocytosis 01/2018 - 01/2007
4	Polycythemia Vera 01/2017 - 06/2008
4	Vomiting 10/2014 - 09/2003
4	Edema (Dropsy) 10/2014 - 02/2012
3	Fibrosis (Cirrhosis) 10/2018 - 07/2015
3	Hyperbilirubinemia 11/2017 - 03/2003
3	Essential Thrombocythemia 01/2017 - 03/2011
3	Hypoxia (Hypoxemia) 04/2016 - 02/2014
3	Atrial Fibrillation 01/2016 - 06/2005
3	Pathologic Complete Response 12/2015 - 06/2002
3	Acute Promyelocytic Leukemia 11/2015 - 06/2002
3	Splenomegaly 08/2015 - 10/2004
2	Breast Neoplasms (Breast Cancer) 06/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

79	Imatinib Mesylate (Gleevec)FDA Link 05/2024 - 07/2002
68	Tyrosine Kinase InhibitorsIBA 05/2024 - 09/2003
41	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2023 - 04/2002
36	Dasatinib (BMS 354825)FDA Link 05/2024 - 05/2008
27	bosutinibIBA 12/2023 - 05/2011
19	Phosphotransferases (Kinase)IBA 12/2020 - 11/2005
15	nilotinib FDA Link 12/2021 - 01/2010
13	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 09/2019 - 06/2002
12	glasdegibIBA 10/2023 - 08/2015
10	Azacitidine (5 Azacytidine)FDA Link 10/2023 - 01/2015
10	bcr-abl Fusion ProteinsIBA 01/2020 - 07/2002
9	ponatinibIBA 01/2019 - 11/2012
8	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2023 - 05/2014
8	Gemtuzumab (Mylotarg)FDA Link 01/2023 - 06/2002
8	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2003
8	fludarabineIBA 01/2018 - 04/2002
6	asciminibIBA 05/2024 - 12/2019
6	LigandsIBA 11/2021 - 01/2011
6	CPX-351IBA 01/2021 - 05/2014
6	quizartinibIBA 01/2021 - 10/2013
6	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021 - 10/2013
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 04/2002
6	Sorafenib (BAY 43-9006)FDA Link 11/2020 - 04/2010
5	Lipase (Acid Lipase)FDA Link 05/2024 - 11/2012
5	Core Binding Factors (Core-Binding Factor)IBA 01/2021 - 07/2009
5	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 12/2015
5	Transaminases (Aminotransferases)IBA 01/2020 - 01/2008
5	ruxolitinibIBA 01/2020 - 08/2012
5	Decitabine FDA Link 01/2020 - 04/2013
5	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017 - 08/2003
5	troxacitabineIBA 12/2003 - 02/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2016
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2016
4	fms-Like Tyrosine Kinase 3IBA 10/2019 - 01/2011
4	Clofarabine (Clolar)FDA Link 01/2018 - 06/2010
4	tipifarnib (R115777)IBA 01/2008 - 07/2002
3	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021 - 12/2012
3	Drug CombinationsIBA 01/2021 - 05/2009
3	InterferonsIBA 01/2021 - 01/2017
3	Alanine Transaminase (SGPT)IBA 12/2018 - 10/2014
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2018 - 10/2014
3	Methotrexate (Mexate)FDA LinkGeneric 02/2016 - 04/2015
3	HomoharringtonineIBA 05/2015 - 10/2013
3	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 12/2003
3	Interferon-alpha (Interferon Alfa)IBA 10/2004 - 07/2002
3	Farnesyltranstransferase (Farnesyltransferase)IBA 12/2003 - 07/2002
2	olutasidenibIBA 05/2024 - 01/2023
2	EnzymesIBA 01/2023 - 08/2015
2	venetoclaxIBA 01/2021 - 01/2020
2	Lenalidomide (CC 5013)FDA Link 01/2021 - 01/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2020 - 10/2014

Therapy/Procedure

115	Therapeutics 05/2024 - 06/2002
35	Drug Therapy (Chemotherapy) 10/2023 - 09/2010
8	Stem Cell Transplantation 09/2019 - 09/2002
7	Drug Tapering 12/2021 - 04/2004
5	Aftercare (After-Treatment) 06/2021 - 02/2003
5	Salvage Therapy 01/2021 - 10/2013
5	Induction Chemotherapy 11/2019 - 10/2013
2	Hematopoietic Stem Cell Transplantation 01/2021 - 10/2020